celastrol has been researched along with Staphylococcal Infections in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Askoura, M; Yehia, FAA; Yousef, N | 1 |
| Abrahão, JS; Andrade, ACDSP; de Brito Magalhães, CL; Duarte, LP; Ferraz, AC; Ferreira, JMS; Lima, WG; Magalhães, JC; Moraes, TFS; Nizer, WSDC; Rodrigues, RAL; Santos, JPD; Vieira-Filho, SA | 1 |
| Dib, C; Leclercq, R; Moniot-Ville, N; Soussy, CJ; Weber, P | 1 |
3 other study(ies) available for celastrol and Staphylococcal Infections
| Article | Year |
|---|---|
Celastrol mitigates staphyloxanthin biosynthesis and biofilm formation in Staphylococcus aureus via targeting key regulators of virulence; in vitro and in vivo approach.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Mice; Molecular Docking Simulation; Pentacyclic Triterpenes; Staphylococcal Infections; Staphylococcus aureus; Virulence; Xanthophylls | 2022 |
Pristimerin isolated from Salacia crassifolia (Mart. Ex. Schult.) G. Don. (Celastraceae) roots as a potential antibacterial agent against Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Chlorocebus aethiops; Gram-Positive Bacteria; Microbial Sensitivity Tests; Pentacyclic Triterpenes; Plant Roots; Salacia; Staphylococcal Infections; Staphylococcus aureus; Triterpenes; Vero Cells | 2021 |
[In vitro activity of the pristinamycin against the isolated staphylococci in the french hospitals in 1999-2000].
Topics: Cross Infection; Drug Resistance, Multiple; France; Humans; Microbial Sensitivity Tests; Pentacyclic Triterpenes; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Triterpenes | 2003 |